Hope Foundation announces John Crowley award for statistical excellence in cancer clinical trials

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Hope Foundation for Cancer Research, the public charity supporting SWOG Cancer Research Network, is launching the John Crowley, PhD, Award, to encourage statistical excellence in clinical trials.

Successful applicants will spend four consecutive weeks in Seattle at the SWOG SDMC, which is colocated on the campuses of the Fred Hutchinson Cancer Research Center and CRAB. Awardees can pursue unique projects in statistical research in collaboration with CRAB and SDMC staff. All related travel and living expenses will be covered for the duration of the residency through support from The Hope Foundation.

Additional information about the award can be found on Hope’s program page. Applications will be accepted through Oct. 15, 2020, and the first residency will take place in the summer of 2021.

Crowley was the long-time group statistician for SWOG and the founder of its statistical partner, Cancer Research And Biostatistics, which today remains part of the SWOG Statistics and Data Management Center in Seattle, WA.

“The award acknowledges the foundational contributions of Dr. Crowley to the field of biostatistics, especially in the design and conduct of cancer clinical trials and survival analysis,” group statistician Michael LeBlanc said in a statement. “His biostatistical innovation and leadership were key to SWOG’s outstanding success conducting high quality and impactful clinical trials.”

In the spirit of Crowley’s innovative methods and committed mentorship, the award provides an opportunity to collaborate with faculty and data management staff at a publicly funded, national multi-center clinical trials organization through a one-month residency in Seattle.

This interactive mentorship program will be a joint effort between CRAB, the SWOG SDMC, and The Hope Foundation.

“Dr. Crowley has been an incredibly influential statistician and mentor with SWOG since he was first elected to lead—and found—the group’s statistical center in 1984,” Johanna Horn, president and CEO of The Hope Foundation, said in a statement.

Table of Contents

YOU MAY BE INTERESTED IN

Shearwood McClelland III’s grandfather was a ditchdigger who dreamed that his six Black daughters would become doctors. McClelland’s mother did not disappoint—she became the first Black woman board-certified in maternal fetal medicine in the history of the United States.  Now, McClelland is the chief medical officer of Cancer Health Equity at the University of Oklahoma...

As oncology enters a new era of precision medicine, the Food and Drug Administration’s evolving biomarker strategy aims to ensure that life-saving therapies are tailored to individual patient needs, fostering safer and more effective treatments.  Historically, therapies were approved with broad indications based on overall efficacy, even when outcomes for biomarker-positive and -negative patients were...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login